ArticleThoracic cancer2025
Awareness of Venous Thromboembolism in Patients With Cancer and Their Carers: Protocol for Systematic Review.
Article in Thoracic cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is an increased risk of venous thromboembolism (VTE) for people living with cancer. However, the awareness of VTE in this population or their carers appears to be low. This lack of awareness may lead to poor outcomes, such as VTE due to low adherence to thromboprophylaxis or delayed hospital presentations with neglected VTE symptoms. This study protocol will guide researchers in conducting a systematic review of existing studies (quantitative, qualitative, or mixed methods) which have assessed VTE awareness among patients living with cancer or their carers. It will also investigate the rates and predictors of VTE awareness in those populations.
methodsThis protocol was designed following the PRISMA-P 2015 statement and the methodological guidance from the PRISMA 2020 statement. Six databases (APA PsycINFO, CINAHL, Google Scholar, Medline, Scopus, and Web of Science Core Collection) will be searched to retrieve all eligible studies. Covidence software will be utilized to assist in the screening of studies for eligibility. A standard data extraction form will be used, and the Mixed Methods Appraisal Tool (MMAT) will be used to assess the methodological quality of each included study. Both a qualitative descriptive approach and meta-analysis will be used for data synthesis and integration where possible. The protocol has been registered with PROSPERO (CRD42025628429).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.